GP2 and Cowden disease: Altogether, the identification of GP2 and CUZD1 as autoantigenic targets in CD ushered in a new era in IBD serology and triggered an impressive number of clinical studies investigating the potential role of the respective autoAbs in the differential diagnosis of IBD [63, 64].